July 30, 2021 - ROSEN LOGO.jpg
TOP RANKED ROSEN LAW FIRM Encourages AST SpaceMobile, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ASTS
May 27, 2024 13:36 ET | The Rosen Law Firm PA
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between November 14,...
Sonatype Named in th
Sonatype Named in the 2023 Gartner® Magic Quadrant™ for Application Security Testing
May 23, 2023 12:33 ET | Sonatype
Fulton, Md., May 23, 2023 (GLOBE NEWSWIRE) -- Sonatype, the pioneer of software supply chain management, today announced it has been named to the 2023 Gartner Magic Quadrant for Application Security...
Sonatype Advances So
Sonatype Advances Software Supply Chain Management with New Platform Enhancements
April 25, 2023 09:22 ET | Sonatype
Fulton, Md., April 25, 2023 (GLOBE NEWSWIRE) -- Sonatype, the pioneer of software supply chain management, today unveiled new product capabilities and refined product names as part of a strengthened...
SURO CAPITAL_highres CROPPED.jpg
SuRo Capital Corp. Will Commence a Modified Dutch Auction Tender Offer to Repurchase up to 3 Million Shares of its Common Stock
March 20, 2023 08:30 ET | SuRo Capital Corp.
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) announced today that it will commence a modified “Dutch Auction”...
Selux Diagnostics
Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors
February 14, 2023 07:30 ET | Selux Diagnostics
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that...
Selux Diagnostics
FDA Clears 'Selux NGP System' for Rapid Antibiotic Susceptibility Testing
January 19, 2023 07:00 ET | Selux Diagnostics
BOSTON, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced it has received...
sintx_grn_blk@4x-8.png
SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022
December 19, 2022 09:00 ET | SINTX Technologies, Inc.
SINTX common stock expected to begin trading on a split-adjusted basis on December 20, 2022 SALT LAKE CITY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) today announced...
SURO CAPITAL_highres CROPPED.jpg
SuRo Capital Corp. Tender Offer Expiring on September 2, 2022 at 5:00 P.M., Eastern Time
August 30, 2022 13:00 ET | SuRo Capital Corp.
Modified Dutch Auction Tender Offer to Repurchase up to 2 Million Sharesat a Price per Share Between $6.00 and $7.00 NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”,...
Qualigen-Logo-Tag.png
Qualigen Therapeutics’ Partner NanoSynex to Present Technology at BioMed Israel
May 10, 2022 09:17 ET | Qualigen Therapeutics, Inc.
Innovative Technology Aims to Accelerate Antimicrobial Susceptibility Test Result Times by Six-Fold CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a...
Qualigen-Logo-Tag.png
Qualigen Therapeutics to Acquire Majority Stake in Diagnostics Technology Company NanoSynex
May 03, 2022 09:17 ET | Qualigen Therapeutics, Inc.
Companies to Collaborate in the Development of Innovative Diagnostics Platform to Combat “Superbugs,” a Rising Global Health Crisis CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Qualigen...